Impact Biomedical Inc (IBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 0 | 0 | 0 | 50 |
| Gross Profit | N/A | N/A | N/A | N/A | 50 |
| Operating Expenses | 1,008 | 803 | 0 | 889 | 800 |
| Operating Income | -1,008 | -803 | N/A | -889 | -750 |
| Interest Expense | 116 | 101 | 0 | 92 | 139 |
| Other Income | 3 | 55 | 0 | 3 | 90 |
| Pre-tax Income | -1,121 | -849 | 0 | -978 | -799 |
| Income Tax | N/A | N/A | N/A | 1,258 | N/A |
| Net Income Continuous | -1,121 | -849 | N/A | -2,236 | -799 |
| Minority Interests | -19 | -192 | N/A | -67 | -67 |
| Net Income | $-1,102 | $-657 | $N/A | $-2,169 | $-732 |
| EPS Basic Total Ops | -0.02 | -0.01 | N/A | -0.03 | 0.00 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | N/A | -0.03 | 0.00 |
| EPS Diluted Total Ops | -0.02 | -0.01 | N/A | -0.03 | 0.00 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | N/A | -0.03 | 0.00 |
| EBITDA(a) | $-728 | $-523 | $N/A | $-610 | $-750 |